dc.contributor.authorAung, Thet Tun
dc.contributor.authorYam, Joey Kuok Hoong
dc.contributor.authorLin, Shuimu
dc.contributor.authorSalleh, Shuhaida Mohamed
dc.contributor.authorGivskov, Michael
dc.contributor.authorLiu, Shouping
dc.contributor.authorLwin, Nyein Chan
dc.contributor.authorYang, Liang
dc.contributor.authorBeuerman, Roger W.
dc.date.accessioned2016-03-08T06:15:42Z
dc.date.available2016-03-08T06:15:42Z
dc.date.issued2015
dc.identifier.citationAung, T. T., Yam, J. K. H., Lin, S., Salleh, S. M., Givskov, M., Liu, S., et al. (2015). Biofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approaches. Antimicrobial Agents and Chemotherapy, 60(1), 24-35.en_US
dc.identifier.issn0066-4804en_US
dc.identifier.urihttp://hdl.handle.net/10220/40220
dc.description.abstractMicrobial infections of the cornea are potentially devastating and can result in permanent visual loss or require vision-rescuing surgery. In recent years, there has been an increasing number of reports on nontuberculous mycobacterial infections of the cornea. Challenges to the management of nontuberculous mycobacterial keratitis include delayed laboratory detection, low index of clinical suspicion, poor drug penetration, slow response to therapy, and prolonged use of antibiotic combinations. The ability of nontuberculous mycobacteria to evade the host immune response and the ability to adhere and to form biofilms on biological and synthetic substrates contribute to the issue. Therefore, there is an urgent need for new antimicrobial compounds that can overcome these problems. In this study, we evaluated the biofilm architectures for Mycobacterium chelonae and Mycobacterium fortuitum in dynamic flow cell chamber and 8-well chamber slide models. Our results showed that mycobacterial biofilms were quite resistant to conventional antibiotics. However, DNase treatment could be used to overcome biofilm resistance. Moreover, we successfully evaluated a new antimicrobial compound (AM-228) that was effective not only for planktonic mycobacterial cells but also for biofilm treatment and was compared favorably with the most successful “fourth-generation” fluoroquinolone, gatifloxacin. Finally, a new treatment strategy emerged: a combination of DNase with an antibiotic was more effective than an antibiotic alone.en_US
dc.description.sponsorshipMOE (Min. of Education, S’pore)en_US
dc.description.sponsorshipMOH (Min. of Health, S’pore)en_US
dc.format.extent12 p.en_US
dc.language.isoenen_US
dc.relation.ispartofseriesAntimicrobial Agents and Chemotherapyen_US
dc.rights© 2015 Aung et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.en_US
dc.subjectdeoxyribonuclease
dc.subjectatypical Mycobacterium
dc.titleBiofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approachesen_US
dc.typeJournal Article
dc.contributor.researchSingapore Centre on Environmental Life Sciences Engineering
dc.contributor.schoolSchool of Biological Sciencesen_US
dc.identifier.doihttp://dx.doi.org/10.1128/AAC.01509-15
dc.description.versionPublished versionen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record